Clinical trials
Recruiting Multiple Myeloma trials in Sweden
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Janssen Research & Development, LLC | 2 |
| Pfizer | 2 |
| AbbVie | 1 |
| AstraZeneca | 1 |
| CellCentric Ltd. | 1 |
| DexTech Medical AB | 1 |
| European Myeloma Network B.V. | 1 |
| Janssen-Cilag Ltd. | 1 |
| Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | 1 |
| Karolinska Institutet | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 15 |
| Hematologic Neoplasms | 1 |
| Leukemia | 1 |
| Leukemia, Myeloid, Acute | 1 |
| Lymphoma, B-Cell | 1 |
| Lymphoma, Non-Hodgkin | 1 |
| Lymphoma, T-Cell, Peripheral | 1 |
| Neoplasms | 1 |
| Neoplasms, Plasma Cell | 1 |
| Recurrence | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.